tiprankstipranks
Trending News
More News >
CCL Products (India) Limited (IN:CCL)
:CCL
India Market
Advertisement

CCL Products (India) Limited (CCL) AI Stock Analysis

Compare
1 Followers

Top Page

IN:CCL

CCL Products (India) Limited

(CCL)

Rating:74Outperform
Price Target:
₹998.00
▲(16.58% Upside)
CCL Products' strong financial performance, particularly in revenue growth and profit margins, is the main driver of its stock score. Technical indicators support a bullish outlook, though the valuation suggests the stock might be overvalued. Careful financial management is needed to address leverage and cash flow concerns.

CCL Products (India) Limited (CCL) vs. iShares MSCI India ETF (INDA)

CCL Products (India) Limited Business Overview & Revenue Model

Company DescriptionCCL Products (India) Limited (CCL) is a leading global coffee manufacturer specializing in the production of instant coffee. The company operates in the food and beverage sector, providing a wide range of coffee products, including spray-dried, agglomerated, freeze-dried instant coffee, and freeze-concentrated liquid coffee. CCL is known for its extensive product portfolio and serves both domestic and international markets, catering to private labels and its own brands.
How the Company Makes MoneyCCL Products generates revenue primarily through the manufacture and sale of instant coffee products. The company's key revenue streams include the export of coffee to various countries, sales under private labels, and retail sales under its own brands. CCL has established significant partnerships with global coffee distributors and private label customers, which contribute to its earnings. The company's production facilities, strategically located in India and Vietnam, enable it to maintain competitive pricing and cater to diverse market demands. Additionally, CCL invests in research and development to innovate and expand its product offerings, further bolstering its revenue potential.

CCL Products (India) Limited Financial Statement Overview

Summary
CCL Products shows strong revenue and profit growth with excellent margins. However, increasing leverage and negative free cash flow pose financial risks that need addressing.
Income Statement
85
Very Positive
CCL Products has demonstrated strong revenue growth with a notable increase from 2024 to 2025. The gross profit margin has consistently improved, and the net profit margin has also shown positive trends, reflecting enhanced operational efficiency. The EBIT and EBITDA margins indicate strong profitability. However, fluctuations in revenue growth rates over the years suggest potential volatility in sales performance.
Balance Sheet
70
Positive
The company's balance sheet reveals a moderate debt-to-equity ratio, suggesting manageable leverage. However, the increasing total debt over the years raises some concerns about financial risk. Return on equity is healthy, indicating efficient use of shareholder funds. The equity ratio remains stable, reflecting a solid asset base relative to liabilities.
Cash Flow
65
Positive
CCL's cash flow situation shows challenges, with free cash flow remaining negative despite improvements in operating cash flow in 2025. The operating cash flow to net income ratio is improving, indicating better cash generation relative to net income. However, the negative free cash flow highlights potential liquidity issues and the need for improved cash management.
BreakdownMar 2025Mar 2024Mar 2022Mar 2023Mar 2021
Income Statement
Total Revenue31.14B26.54B14.62B20.71B12.42B
Gross Profit12.72B9.44B6.47B9.42B5.54B
EBITDA5.64B4.49B3.35B4.03B3.01B
Net Income3.10B2.50B2.04B2.84B1.82B
Balance Sheet
Total Assets42.41B35.36B20.70B25.97B17.88B
Cash, Cash Equivalents and Short-Term Investments969.43M1.70B527.81M937.54M1.17B
Total Debt18.15B16.22B6.51B9.20B5.59B
Total Liabilities22.74B18.62B8.19B11.15B7.01B
Stockholders Equity19.67B16.74B12.51B14.82B10.87B
Cash Flow
Free Cash Flow-1.28B-4.58B-891.91M-1.34B162.19M
Operating Cash Flow2.90B553.78M1.01B1.98B1.71B
Investing Cash Flow-4.16B-5.14B-1.90B-3.32B-1.53B
Financing Cash Flow530.02M5.59B250.64M1.64B636.27M

CCL Products (India) Limited Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price856.05
Price Trends
50DMA
855.52
Positive
100DMA
755.42
Positive
200DMA
713.22
Positive
Market Momentum
MACD
6.29
Positive
RSI
49.70
Neutral
STOCH
39.56
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:CCL, the sentiment is Neutral. The current price of 856.05 is below the 20-day moving average (MA) of 864.53, above the 50-day MA of 855.52, and above the 200-day MA of 713.22, indicating a neutral trend. The MACD of 6.29 indicates Positive momentum. The RSI at 49.70 is Neutral, neither overbought nor oversold. The STOCH value of 39.56 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:CCL.

CCL Products (India) Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (57)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
₹115.52B37.07
0.58%22.22%19.04%
73
Outperform
₹103.23B19.11
0.82%15.69%10.74%
72
Outperform
₹158.57B25.55
0.66%12.52%1.89%
67
Neutral
₹180.68B89.31
0.14%11.69%-28.52%
67
Neutral
₹87.91B62.75
0.34%15.39%-0.22%
67
Neutral
₹123.39B37.72
0.31%10.63%7.53%
57
Neutral
$3.22B9.46-34.32%2.94%-25.56%-353.61%
* Consumer Goods Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:CCL
CCL Products (India) Limited
856.05
198.88
30.26%
IN:BECTORFOOD
Mrs. Bector's Food Specialities Ltd.
1,359.30
-77.98
-5.43%
IN:BIKAJI
Bikaji Foods International Ltd.
716.60
-117.60
-14.10%
IN:KRBL
KRBL Limited
486.30
205.16
72.97%
IN:LTFOODS
LT Foods Limited
458.90
147.99
47.60%
IN:ZYDUSWELL
Zydus Wellness Limited
1,946.95
-267.99
-12.10%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 08, 2025